An in-situ forming implant formulation of naltrexone with minimum initial burst release using mixture of PLGA copolymers and ethyl heptanoate as an additive: In-vitro, ex-vivo, and in-vivo release evaluation

Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Drug Discovery

Hossein Kamali, Elham Khodaverdi, Farzin Hadizadeh, Rezvan Yazdian-Robati, Ali Haghbin, Golamhossein Zohuri,